Use of clofarabine for acute childhood leukemia
A Pession, R Masetti, K Kleinschmidt, A MartoniPediatric Oncology and Hematology “Lalla Seràgnoli”, University of Bologna, ItalyAbstract: A second-generation of purine nucleoside analogs, starting with clofarabine, has been developed in the course of the se...
Main Authors: | A Pession, R Masetti, K Kleinschmidt, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-06-01
|
Series: | Biologics : Targets & Therapy |
Online Access: | http://www.dovepress.com/use-of-clofarabine-for-acute-childhood-leukemia-a4654 |
Similar Items
-
Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine
by: Rie Nishi, et al.
Published: (2020-10-01) -
The Role of HDACs Inhibitors in Childhood and Adolescence Acute
Leukemias
by: Riccardo Masetti, et al.
Published: (2011-01-01) -
Clofarabine Improves Relapse-Free Survival of Acute Myeloid Leukemia in Younger Adults with Micro-Complex Karyotype
by: Laurène Fenwarth, et al.
Published: (2019-12-01) -
A real-world study on Clofarabine and Cytarabine combination in patients with relapsed/refractory acute myeloid leukemia
by: Claudio Fozza, et al.
Published: (2019-04-01) -
Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia
by: Prachi Jain, et al.
Published: (2017-01-01)